On 1st June at Bush House, Aldwych in London, Innovation Forum King’s College London will be hosting an event on The Future of Science Innovation: Building Collaborations between Academia Start-ups and Industry

The event will include an interactive panel discussion that will aim to dissect key factors for successfully starting and maintaining industry-start-up collaborations, and how can these be improved to drive innovation.

Points of interest will include:

• What are the advantages for start-ups, especially those from universities, to collaborate with corporates?

• What are major barriers for start-ups in starting and maintaining successful relationships with corporates?

• What have policymakers already done to help start-ups from universities initiate collaborations with industry, and how could these policies be improved?

We welcome policymakers, academics and entrepreneurs working with science start-ups and corporates.

AGENDA:

17.45 – 18.15: Registration
18.15 – 18.30: Introduction of KCLIF and Panelists
– Prof. Jackie Hunter CBE, CEO of Benevolent Bio
– Prof. Stefan Allesch-Taylor CBE, Serial Entrepreneur
– Dr. Jim Totty, Managing Partner at STIL
– Dr. Duncan Young, Associate Director at Scientific Partnering and Alliances, AstraZeneca

18.30 – 19.30: Panel Discussion
19.30 – 20.00: Q&A
20.00 – Onwards: Networking with Drinks and Canapés

PANELISTS:

Prof. Jackie Hunter, CEO of Benevolent Bio, has over thirty years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation and most recently was Chief Executive of the Biotechnology and Biological Sciences Research Council.

Prof. Stefan Allesch-Taylor CBE, a London-based financier, entrepreneur, charity chairman and philanthropist, with over 25 years’ experience of business startups, turnarounds and public companies. He has served on Boards in Europe and the USA as CEO, Chairman or senior non-executive director on both public and private companies.

Dr. Duncan Young, Associate Director in the Scientific Partnering and Alliances team at AstraZeneca – responsible for university collaborations, oncology business development and open innovation interactions for the portfolio. Duncan has a wealth of experience in the interface between industry and academia, technology transfer and translational research.

Dr. Jim Totty, Jim has 20 years’ experience in sustainable and clean technology, gained through his previous roles including Citi, PricewaterhouseCoopers and earlier academic work. Kim is a Chartered Financial Analyst, and holds an MA in Physics from the University of Cambridge and a MSc and PhD in Physics from Imperial College, University of London.

For more information and tickets visit: https://www.eventbrite.co.uk/e/the-future-of-science-innovation-tickets-33813660569